Lab-Grown Skin Acquires Volar Traits in Trial

Johns Hopkins researchers partially transformed ordinary human skin into volar skin in a phase I clinical trial published November 10.

Updated on Nov. 11, 2026 in Biotech

Lab-Grown Skin Acquires Volar Traits in Trial

Johns Hopkins Medicine researchers partially transformed ordinary human skin cells into volar skin, the thick, sensitive skin found on palms and soles. The phase I trial enrolled 10 healthy adult volunteers and was published in the Journal of Investigative Dermatology.

Why it matters

Limb loss often removes volar skin, making enough tissue for treatment difficult to source, and bruising at prosthetic attachment sites limits daily prosthetic use for millions. An estimated 2 million people in the U.S. live with limb loss, so a method to create volar-like skin could address a real gap in care.

In a phase I trial of 10 healthy adults with a mean age of 36.5, skin treated with volar fibroblasts gained thickness and elasticity and kept volar-like traits for up to five months. Whether the immune response seen at treatment sites affects long-term transformation has not yet been determined.

The players

Johns Hopkins Medicine

A medical institution in Baltimore, Maryland, whose researchers conducted the phase I trial on volar skin transformation.

National Institutes of Health

The U.S. federal agency that funded the phase I clinical trial, as the largest public funder of biomedical research in the country.

Maryland Stem Cell Research Fund

A state-funded program in Maryland that supported the study alongside federal funding.

The details

Researchers cultivated scalp and sole fibroblasts from each participant and injected them into separate sites, alongside a single collagen-PMMA filler injection and control sites. Collagen-PMMA did not prevent the skin changes, and it caused fibroblasts, blood vessel cells, and immune cells to gather at every treatment site without altering effectiveness over the five-month study.

Timeline

  1. Previous trial: volar fibroblasts gave non-volar skin volar-like traits for up to five months.

  2. Two-month follow-up: researchers measured skin thickness, firmness, and cellular changes.

  3. Five-month evaluation: final assessment of skin thickness, firmness, and cellular changes.

  4. Nov. 10, 2026: study published in the Journal of Investigative Dermatology.

Big Picture

The study builds on state-backed stem cell research through the Maryland Stem Cell Research Fund, extending regenerative work from earlier tissue studies toward functional skin replacement. It marks a move from broad tissue regeneration toward site-specific skin properties that matter to prosthetic users.

For people living with limb loss, skin that resists bruising could eventually improve comfort and daily prosthetic use. The research is still early, and no treatment is currently available to patients.

The takeaway

Lab-grown skin that acquires volar traits could eventually reduce prosthetic discomfort for people with limb loss. Patients should watch for longer trials before expecting access to any such therapy.

What happens next

Longer studies will examine how the immune response affects transplanted volar cells and whether growth factors or physical stimulation can stabilize volar skin characteristics.

Further reading

Explore more biotech coverage for context on regenerative medicine research.

More information

Read the full Journal of Investigative Dermatology study03870-4/fulltext) on volar fibroblast skin transformation.

Source note: This article includes information reported by News-Medical.